Lexeo Therapeutics, Inc. Common Stock
USD4.66
+0.11 (+2.42%)
CEO
R. Nolan Townsend
IPO Date
2023-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.61
Prev. Close
$4.55
Day Low
$4.56
Day High
$4.72
52W Low
$3.60
52W High
$10.99
Market Cap
$0.37B
Volume
0.33M
| 4,641 |
| $4.49 |
| 1 Jul 2026 | Otero Jose Manuel | Chief Operating Officer | A-Award | Acquired | 12,060 | $0.00 |
| 1 Jul 2026 | Otero Jose Manuel | Chief Operating Officer | S-Sale | Disposed | 4,666 | $4.48 |
| 1 Jul 2026 | Bhalla Narinder Pal | Chief Medical Officer | A-Award | Acquired | 55,000 | $0.00 |
| 1 Jul 2026 | Bhalla Narinder Pal | Chief Medical Officer | S-Sale | Disposed | 22,306 | $4.42 |
| 1 Jul 2026 | Townsend Richard Nolan | director, officer: Chief Executive Officer | A-Award | Acquired | 67,000 | $0.00 |
| 1 Jul 2026 | Townsend Richard Nolan | director, officer: Chief Executive Officer | S-Sale | Disposed | 25,947 | $4.48 |
| 29 Jun 2026 | Altschuler Steven | director | A-Award | Acquired | 35,000 | $4.70 |
| 29 Jun 2026 | Agger Mette Kirstine | director | A-Award | Acquired | 35,000 | $4.70 |